Bioluminescence Imaging in Mouse Models Quantifies β Cell Mass in the Pancreas and After Islet Transplantation
暂无分享,去创建一个
Marcela Brissova | John Virostko | E. Jansen | A. Powers | M. Brissova | E. Duco Jansen | Zhongyi Chen | Aramandla Radhika | Greg Poffenberger | Joshua Gilchrist | Brian Coleman | Maureen Gannon | Alvin C. Powers | M. Gannon | Zhongyi Chen | G. Poffenberger | A. Radhika | John Virostko | J. Gilchrist | Brian Coleman | Greg Poffenberger | E. Jansen
[1] Tohru Takahashi,et al. Differential volumetry of A, B and D cells in the pancreatic islets of diabetic and nondiabetic subjects. , 1979, The Tohoku journal of experimental medicine.
[2] Luigi Biancone,et al. Magnetic resonance imaging of gadolinium‐labeled pancreatic islets for experimental transplantation , 2007, NMR in biomedicine.
[3] Marcela Brissova,et al. Intraislet endothelial cells contribute to revascularization of transplanted pancreatic islets. , 2004, Diabetes.
[4] Sanjiv Sam Gambhir,et al. Bioluminescent monitoring of islet graft survival after transplantation. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.
[5] D. Piston,et al. Reduction in Pancreatic Transcription Factor PDX-1 Impairs Glucose-stimulated Insulin Secretion* , 2002, The Journal of Biological Chemistry.
[6] S. Gambhir,et al. Lu, Y. et al. Bioluminescent monitoring of islet graft survival after transplantation. Mol. Ther. 9, 428-435 , 2004 .
[7] S. Gambhir,et al. Quantitative micro positron emission tomography (PET) imaging for the in vivo determination of pancreatic islet graft survival , 2006, Nature Medicine.
[8] C. Malloy,et al. A new class of macrocyclic lanthanide complexes for cell labeling and magnetic resonance imaging applications. , 2005, Journal of the American Chemical Society.
[9] Brian Rutt,et al. Imaging Islets Labeled With Magnetic Nanoparticles at 1.5 Tesla , 2006, Diabetes.
[10] C. Wright,et al. Reduced PDX-1 expression impairs islet response to insulin resistance and worsens glucose homeostasis. , 2005, American journal of physiology. Endocrinology and metabolism.
[11] R. Carr,et al. Measurements of insulin secretory capacity and glucose tolerance to predict pancreatic beta-cell mass in vivo in the nicotinamide/streptozotocin Göttingen minipig, a model of moderate insulin deficiency and diabetes. , 2003, Diabetes.
[12] T. Desai,et al. Functional MR Microimaging of Pancreatic β-Cell Activation , 2006, Cell transplantation.
[13] A. Anilkumar,et al. An encapsulation system for the immunoisolation of pancreatic islets , 1997, Nature Biotechnology.
[14] S. Bonner-Weir,et al. Partial pancreatectomy in the rat and subsequent defect in glucose-induced insulin release. , 1983, The Journal of clinical investigation.
[15] R. Robertson. Islet transplantation as a treatment for diabetes - a work in progress. , 2004, The New England journal of medicine.
[16] S. Bonner-Weir,et al. Function, Mass, and Replication of Porcine and Rat Islets Transplanted into Diabetic Nude Mice , 1995, Diabetes.
[17] T. Desai,et al. Functional MR microimaging of pancreatic beta-cell activation. , 2006, Cell transplantation.
[18] B. Rice,et al. Three-dimensional reconstruction of in vivo bioluminescent sources based on multispectral imaging. , 2007, Journal of biomedical optics.
[19] G. Dai,et al. In vivo multimodal imaging of transplanted pancreatic islets , 2006, Nature Protocols.
[20] S. Bonner-Weir,et al. A selective decrease in the beta cell mass of human islets transplanted into diabetic nude mice. , 1995, Transplantation.
[21] R. Alejandro,et al. Pancreatic fate of a 125I‐labelled mouse monoclonal antibody directed against pancreatic B‐cell surface ganglioside(s) in control and diabetic rats , 2001, Cell biochemistry and function.
[22] D. Kaufman,et al. In Vivo Bioluminescence Imaging of Transplanted Islets and Early Detection of Graft Rejection , 2006, Transplantation.
[23] R. Weissleder,et al. Noninvasive in vivo measurement of beta-cell mass in mouse model of diabetes. , 2001, Diabetes.
[24] R. V. Van Heertum,et al. Longitudinal noninvasive PET-based beta cell mass estimates in a spontaneous diabetes rat model. , 2006, The Journal of clinical investigation.
[25] Peter Girman,et al. MRI of transplanted pancreatic islets , 2004, Magnetic resonance in medicine.
[26] Habib Zaidi,et al. Positron-emission tomography imaging of early events after transplantation of islets of Langerhans. , 2005, Transplantation.
[27] Kojima. Structure and function , 2005 .
[28] Masafumi Oshiro,et al. Visualizing Gene Expression in Living Mammals Using a Bioluminescent Reporter , 1997, Photochemistry and photobiology.
[29] Soo-young Park,et al. Optical imaging of pancreatic beta cells in living mice expressing a mouse insulin I promoter‐firefly luciferase transgene , 2005, Genesis.
[30] E. Ryan,et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. , 2000, The New England journal of medicine.
[31] P. Lacy. The pancreatic beta cell. Structure and function. , 1967, The New England journal of medicine.
[32] David K. Stevenson,et al. Rapid in vivo functional analysis of transgenes in mice using whole body imaging of luciferase expression , 2001, Transgenic Research.
[33] M. Straume,et al. Decrease in beta-cell mass leads to impaired pulsatile insulin secretion, reduced postprandial hepatic insulin clearance, and relative hyperglucagonemia in the minipig. , 2001, Diabetes.
[34] Steven J Smith,et al. In vivo monitoring of pancreatic beta-cells in a transgenic mouse model. , 2006, Molecular imaging.
[35] E. Jansen,et al. Current status of imaging pancreatic islets , 2006, Current diabetes reports.
[36] A. M. James Shapiro,et al. TOWARD DEVELOPMENT OF IMAGING MODALITIES FOR ISLETS AFTER TRANSPLANTATION: INSIGHTS FROM THE NATIONAL INSTITUTES OF HEALTH WORKSHOP ON BETA CELL IMAGING , 2004, Transplantation.
[37] Anna Moore,et al. In vivo imaging of islet transplantation , 2006, Nature Medicine.
[38] E. Jansen,et al. Factors Influencing Quantification of in Vivo Bioluminescence Imaging: Application to Assessment of Pancreatic Islet Transplants , 2004 .
[39] S. Bonner-Weir,et al. Correlations of in vivo beta-cell function tests with beta-cell mass and pancreatic insulin content in streptozocin-administered baboons. , 1991, Diabetes.
[40] Alvin C. Powers,et al. Assessment of Human Pancreatic Islet Architecture and Composition by Laser Scanning Confocal Microscopy , 2005, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[41] D. Jirák,et al. Magnetic Resonance Imaging of Pancreatic Islets in Tolerance and Rejection , 2005, Transplantation.
[42] C. Wright,et al. Regulatory regions driving developmental and tissue-specific expression of the essential pancreatic gene pdx1. , 2001, Developmental biology.
[43] M. Phelps,et al. Noninvasive imaging of islet grafts using positron-emission tomography. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[44] S. Bonner-Weir,et al. Correlations of In Vivo β-Cell Function Tests With β-Cell Mass and Pancreatic Insulin Content in Streptozocin-Administered Baboons , 1991, Diabetes.
[45] D. Steiner,et al. Control of insulin gene expression in pancreatic beta-cells and in an insulin-producing cell line, RIN-5F cells. I. Effects of glucose and cyclic AMP on the transcription of insulin mRNA. , 1985, The Journal of biological chemistry.
[46] G. Bell,et al. Transgenic mice with green fluorescent protein-labeled pancreatic β-cells , 2003 .
[47] D. Steiner,et al. Control of insulin gene expression in pancreatic beta-cells and in an insulin-producing cell line, RIN-5F cells. II. Regulation of insulin mRNA stability. , 1985, The Journal of biological chemistry.
[48] H. Kennedy,et al. Glucose generates sub-plasma membrane ATP microdomains in single islet beta-cells. Potential role for strategically located mitochondria. , 1999, The Journal of biological chemistry.
[49] D. Harlan,et al. Assessment of Pancreatic Islet Mass after Islet Transplantation Using In Vivo Bioluminescence Imaging , 2005, Transplantation.
[50] N. Buchheimer,et al. Neurofunctional imaging of the pancreas utilizing the cholinergic PET radioligand [18F]4-fluorobenzyltrozamicol , 2004, European Journal of Nuclear Medicine and Molecular Imaging.
[51] G. Bell,et al. Transgenic mice with green fluorescent protein-labeled pancreatic beta -cells. , 2003, American journal of physiology. Endocrinology and metabolism.
[52] J. Leahy. In vivo imaging of islet transplantation , 2007 .
[53] A. Alavi,et al. In vitro and in vivo evaluation of novel glibenclamide derivatives as imaging agents for the non-invasive assessment of the pancreatic islet cell mass in animals and humans. , 2005, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.
[54] K. Herold,et al. Visualizing pancreatic β-cell mass with [11C]DTBZ , 2006 .
[55] R. Weissleder,et al. Noninvasive In Vivo Measurement of β-Cell Mass in Mouse Model of Diabetes , 2001 .
[56] Matthias Stuber,et al. Magnetic resonance–guided, real-time targeted delivery and imaging of magnetocapsules immunoprotecting pancreatic islet cells , 2007, Nature Medicine.
[57] E Duco Jansen,et al. Validation of luminescent source reconstruction using single-view spectrally resolved bioluminescence images. , 2007, Applied optics.
[58] R. V. Van Heertum,et al. Visualizing pancreatic beta-cell mass with [11C]DTBZ. , 2006, Nuclear medicine and biology.